Platelet and Plasma Market Size By Component (Platelets, Plasma), By Application (Hemophilia, Thrombocytopenia, Perioperative Indications, Platelet Function Disorders, Coagulation Factor Deficiencies, Thrombotic Thrombocytopenic Purpura, Hemorrhage, Liver Disease), By Distribution Channel (Hospitals, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook, Application Potential, Growth Potential, Price Trend, Competitive Market Share & Forecast, 2020 - 2026

Platelet and Plasma Market Size

Platelet and Plasma Market size was more than USD 6.1 billion in 2019 and will witness 2.2% CAGR during 2020 to 2026. Platelet and plasma are critical parts of the treatment for several serious health problems. Platelets are tiny cell components of blood that helps in formation of blood clot to stop bleeding while plasma is a liquid component of blood that takes hormones, nutrients, and proteins to the different parts of body.
 

Increasing demand of platelet and plasma for the treatment of life-threatening diseases and deficiencies such as hemophilia, thrombocytopenia, coagulation factor deficiencies, liver disease along with other blood disorders will upsurge the industry growth. Favourable reimbursement policies in developed countries will further boost market demand over the projected timeline.
 

Platelet and Plasma Market Analysis

Increasing demand for blood transfusion procedures in Europe will propel the market growth over the forecast period. Recent years have seen an upsurge in number of blood banks in European countries to full fill the growing demand for platelet and plasma that stimulates the market growth. Blood transfusion in these countries is often a part of specialized healthcare system. For instance, in Norwegian hospitals there are currently more than 60 blood banks that provide all blood components including platelet and plasma. Numerous blood donations occur at accredited and certified blood banks. This will drive the market growth over the projected timeline.
 

Also, according to the World Health Organization (WHO), every year more than 115 million units of donated blood are collected worldwide and around 42% of these are collected in high-income nations of America and Europe. Increasing number of blood donation camps will significantly propel the market demand over forecast period.
 

The platelet market accounted for nearly USD 4.1 billion value in 2019, owing to the growing number of trauma cases and road accidents. Platelets play a critical role during surgeries and help in formation of blood clots to prevent excess bleeding.
 

Use of platelets and its derivatives for quick healing in various surgical procedures such as cardiothoracic surgery, maxillofacial diseases, and other musculoskeletal diseases is increasing globally. They are also used prominently in various orthopedic treatments such as total knee arthroplasty, osteoarthritis of shoulder, bone and ligament regeneration as well as soft tissue healing. This is anticipated to drive the segmental growth.
 

Hemophilia segment accounted for around 5.5% market share in 2019 and will witness significant market growth over the forecast period. The growth is attributed to increasing number of traumatic injuries leading to hemorrhage and imbalance of body hemostatic mechanism. Such factors will increase demand for blood transfusion leading to segmental growth. Hemophilia is more prevalent in patients with history of easy bleeding and bruising followed by surgery and is genetically transferred from one generation to another that will further augment the market growth.
 

Hospitals accounted for around 62% market share in 2019 and is estimated to grow significantly over the coming years. The growth of this segment is attributed to the higher availability of blood components such as platelet and plasma in hospitals, thus boosting the segmental growth.
 

The growth of the segment is also attributed to the growing number of surgeries that require blood transfusion. These procedures are mostly performed in hospital settings, thereby fostering the segment growth. Additionally, increasing number of well-established hospitals coupled with rising healthcare coverage is a positive impact rendering factor for the market growth.
 

North America platelet and plasma market is anticipated to hold a significant market share in 2019 and will witness over 1.5% CAGR during the analysis period. Regional growth is primarily attributed to favorable regulations pertaining to use of platelet and plasma derived products. Also, increasing number of patients suffering from obesity, cancer, cardiothoracic disorders as well as growing incidences of neurological conditions will increase the demand for platelet and plasma, thereby propelling the regional market growth.
 

Moreover, rising healthcare expenditure and various initiatives by organizations such as setting-up blood donation campaigns will further boost the regional market growth.
 

Platelet and Plasma Market Share

Some of the eminent industry participants operating in the platelet & plasma market share include:

• America’s Blood Centers
• American Association of Blood Banks
• Blood Centers of America
• Indian Red Cross
• European Blood Alliance
• Japanese Red Cross
• Italian Red Cross
• OneBlood
• South African Red Cross Society
• American Red Cross.

The notable market participants are strategically implementing several business strategies to increase the awareness among people pertaining to blood donation in order to meet the demand for platelet and plasma.
 

Some of the recent industry developments:

• In April 2020, in the wake of COVID-19 pandemic, OneBlood, a not-for-profit blood center, initiated the collection of platelet and plasma from recovered patients of coronavirus. The collected plasma is transfused into the COVID-19 affected patients that aids them in recovery. The company’s active participation will serve for its growth in the industry.
   
• In April 2018, American Red Cross relaunched the redesigned RedCrossBlood.org. This approach helped the donors to make donations more conveniently through improved content search, advanced personalization, and user-friendly interface. The launch was aimed to attract more donors that provided boost to the industry.
   

The platelet and plasma industry research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2015 to 2026, for the following segments:

Click here to Buy Section of this Report

By Component, 2015 – 2026 (USD Million)

• Platelets
• Plasma

By Application, 2015 – 2026 (USD Million)

• Hemophilia
• Thrombocytopenia
• Perioperative indications
• Platelet function disorders
• Other platelet applications
• Coagulation factor deficiencies
• Thrombotic thrombocytopenic purpura
• Hemorrhage
• Liver disease
• Other plasma applications

By Distribution Channel, 2015 – 2026 (USD Million)

• Hospitals
• Ambulatory surgical centers
• Others

The above information is provided for the following geographies:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico 
• Middle East
  • South Africa
  • Saudi Arabia